These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21654740)

  • 1. The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.
    Johnson S; Stockmeier CA; Meyer JH; Austin MC; Albert PR; Wang J; May WL; Rajkowska G; Overholser JC; Jurjus G; Dieter L; Johnson C; Sittman DB; Ou XM
    Neuropsychopharmacology; 2011 Sep; 36(10):2139-48. PubMed ID: 21654740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway.
    Ou XM; Chen K; Shih JC
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10923-8. PubMed ID: 16829576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of KLF11 (TIEG2), a monoamine oxidase B transcriptional activator in the prefrontal cortex of human alcohol dependence.
    Udemgba C; Johnson S; Stockmeier CA; Luo J; Albert PR; Wang J; May WL; Rajkowska G; Harris S; Sittman DB; Ou XM
    Alcohol Clin Exp Res; 2014 Jan; 38(1):144-51. PubMed ID: 23915421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence revealing deregulation of the KLF11-MAO A pathway in association with chronic stress and depressive disorders.
    Harris S; Johnson S; Duncan JW; Udemgba C; Meyer JH; Albert PR; Lomberk G; Urrutia R; Ou XM; Stockmeier CA; Wang JM
    Neuropsychopharmacology; 2015 May; 40(6):1373-82. PubMed ID: 25502632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidases in major depressive disorder and alcoholism.
    Duncan J; Johnson S; Ou XM
    Drug Discov Ther; 2012 Jun; 6(3):112-22. PubMed ID: 22890201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B.
    Chen K; Ou XM; Wu JB; Shih JC
    Mol Pharmacol; 2011 Feb; 79(2):308-17. PubMed ID: 20980443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R1, a novel repressor of the human monoamine oxidase A.
    Chen K; Ou XM; Chen G; Choi SH; Shih JC
    J Biol Chem; 2005 Mar; 280(12):11552-9. PubMed ID: 15654081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.
    Rekkas PV; Wilson AA; Lee VW; Yogalingam P; Sacher J; Rusjan P; Houle S; Stewart DE; Kolla NJ; Kish S; Chiuccariello L; Meyer JH
    JAMA Psychiatry; 2014 Aug; 71(8):873-9. PubMed ID: 24898155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.
    Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH
    J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1.
    Ou XM; Chen K; Shih JC
    J Biol Chem; 2006 Jul; 281(30):21512-21525. PubMed ID: 16728402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.
    Kolla NJ; Chiuccariello L; Wilson AA; Houle S; Links P; Bagby RM; McMain S; Kellow C; Patel J; Rekkas PV; Pasricha S; Meyer JH
    Biol Psychiatry; 2016 Jan; 79(2):117-26. PubMed ID: 25698585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.
    Moriguchi S; Wilson AA; Miler L; Rusjan PM; Vasdev N; Kish SJ; Rajkowska G; Wang J; Bagby M; Mizrahi R; Varughese B; Houle S; Meyer JH
    JAMA Psychiatry; 2019 Jun; 76(6):634-641. PubMed ID: 30840042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.
    Miguel-Hidalgo JJ; Whittom A; Villarreal A; Soni M; Meshram A; Pickett JC; Rajkowska G; Stockmeier CA
    J Affect Disord; 2014 Apr; 158():62-70. PubMed ID: 24655767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.
    Karolewicz B; Klimek V; Zhu H; Szebeni K; Nail E; Stockmeier CA; Johnson L; Ordway GA
    Brain Res; 2005 May; 1043(1-2):57-64. PubMed ID: 15862518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase a expression is vital for embryonic brain development by modulating developmental apoptosis.
    Wang CC; Borchert A; Ugun-Klusek A; Tang LY; Lui WT; Chu CY; Billett E; Kuhn H; Ufer C
    J Biol Chem; 2011 Aug; 286(32):28322-30. PubMed ID: 21697081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.
    Meyer JH; Ginovart N; Boovariwala A; Sagrati S; Hussey D; Garcia A; Young T; Praschak-Rieder N; Wilson AA; Houle S
    Arch Gen Psychiatry; 2006 Nov; 63(11):1209-16. PubMed ID: 17088501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response.
    Yu YW; Tsai SJ; Hong CJ; Chen TJ; Chen MC; Yang CW
    Neuropsychopharmacology; 2005 Sep; 30(9):1719-23. PubMed ID: 15956990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal function of monoamine oxidase-A in comorbid major depressive disorder and cardiovascular disease: pathophysiological and therapeutic implications (review).
    Machado-Vieira R; Mallinger AG
    Mol Med Rep; 2012 Nov; 6(5):915-22. PubMed ID: 22948532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms.
    Chiuccariello L; Houle S; Miler L; Cooke RG; Rusjan PM; Rajkowska G; Levitan RD; Kish SJ; Kolla NJ; Ou X; Wilson AA; Meyer JH
    Neuropsychopharmacology; 2014 Mar; 39(4):973-80. PubMed ID: 24154665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.